CJ-40001

· HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJ-40001, covering 2018-05-31 to 2018-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics Study of CJ-40001 and NESP® After Single Dose Administration in Health Male Volunteers [Phase 1]